The pathogenesis of alcoholic liver disease (ALD) remains poorly understood but is likely a multihit pathophysiological process. Here, we propose a hypothesis of how early mitochondrial adaptations for alcohol metabolism lead to ALD pathogenesis. Acutely, ethanol (EtOH) feeding causes a near doubling of hepatic EtOH metabolism and oxygen consumption within 2 to 3 hours. This swift increase in alcohol metabolism (SIAM) is an adaptive response to hasten metabolic elimination of both EtOH and its more toxic metabolite, acetaldehyde (AcAld). In association with SIAM, EtOH causes widespread hepatic mitochondrial depolarization (mtDepo), which stimulates oxygen consumption. In parallel, voltage-dependent anion channels (VDAC) in the mitochondrial outer membrane close. Together, VDAC closure and respiratory stimulation promote selective and more rapid oxidation of EtOH first to AcAld in the cytosol and then to nontoxic acetate in mitochondria, since membrane-permeant AcAld does not require VDAC to enter mitochondria. VDAC closure also inhibits mitochondrial fatty acid oxidation and ATP release, promoting steatosis and a decrease in cytosolic ATP. After acute EtOH, these changes revert as EtOH is eliminated with little hepatocellular cytolethality. mtDepo also stimulates mitochondrial autophagy (mitophagy). After chronic high EtOH exposure, the capacity to process depolarized mitochondria by mitophagy becomes compromised, leading to intra-and extracellular release of damaged mitochondria, mitophagosomes, and/or autolysosomes containing mitochondrial damage-associated molecular pattern (mtDAMP) molecules. mtDAMPs cause inflammasome activation and promote inflammatory and profibrogenic responses, causing hepatitis and fibrosis. We propose that persistence of mitochondrial responses to EtOH metabolism becomes a tipping point, which links initial adaptive EtOH metabolism to maladaptive changes initiating onset and progression of ALD.
A LCOHOL IS CONSUMED worldwide, and excessive alcohol consumption leads to alcoholic liver disease (ALD) (Rehm et al., 2013) . In the United States, approximately two-thirds of adults drink alcohol, and more than 2.5 million people have ALD (Chacko and Reinus, 2016; Kim et al., 2002) . The major pathological features of human ALD are steatosis, hepatitis, and fibrosis/cirrhosis, which often coexist and eventually progress to end-stage liver disease and/or liver cancer (Bataller and Gao, 2015; Chacko and Reinus, 2016; Ishak et al., 1991) . ALD accounts for about half of global mortality due to cirrhosis (Gao and Bataller, 2011; Rehm et al., 2013) . In severe alcoholic hepatitis (AH), mortality is 30 to 50% and exceeds 50% in patients with cirrhosis (Beier et al., 2011; Fung and Pyrsopoulos, 2017) . Estimated alcohol-related healthcare costs in the United States are more than $26 billion (Kim et al., 2002) . Therefore, ALD remains a major concern for public health and medicine.
ALD is a multistage disease with a pathogenesis generally recognized to be mediated by multihit mechanisms (Szabo and Petrasek, 2017; Tsukamoto et al., 2009) . In recent years, proinflammatory gut microbiome-liver interactions, adipose tissue dysfunction, genetic polymorphisms, epigenetic changes, perturbation of methionine metabolism, endoplasmic reticulum (ER) stress, and various mitochondrial alterations have all been proposed to contribute to ALD pathogenesis Szabo and Petrasek, 2017; Wang et al., 2016a,b; Williams et al., 2014; Xu et al., 2017) . Despite extensive study, mechanisms by which ethanol (EtOH) initiates hepatic damage and promotes ALD progression remain incompletely understood.
Many early studies have shown mitochondrial alterations in ALD (Hoek and Pastorino, 2004; Hoek et al., 2002; Ishak et al., 1991; Mansouri et al., 2018) . Mitochondrial morphological changes, such as megamitochondria, are an early and constant finding in ALD patients (Hoek et al., 2002; Ishak et al., 1991; Matsuhashi et al., 1998) . Moreover, adaptive alcohol metabolism leads to a mitochondrial respiratory burst, an effect that depends on Kupffer cell activation (Bradford and Rusyn, 2005; Forman et al., 1988; Rivera et al., 1998; Thurman et al., 1982; Yuki and Thurman, 1980b) . Deletions of mitochondrial DNA (mtDNA) are also common in ALD patients Larosche et al., 2010) . Thus, mitochondrial stress and damage are likely important early events in the "multihit" pathogenesis of ALD. This article presents a unifying hypothesis of how mitochondrial adaptations that acutely augment alcohol metabolism and detoxification also promote the pathological features of chronic ALD, including steatosis, inflammation, and fibrosis.
ADAPTIVE ALCOHOL METABOLISM-RELATED MITOCHONDRIAL ALTERATIONS

Hepatic EtOH Metabolism
EtOH undergoes 2-step oxidation to acetaldehyde (AcAld) and then to acetate, a process occurring predominantly in the liver (Fig. 1 ). Alcohol dehydrogenase (ADH) in the cytosol, cytochrome P450 2E1 (CYP2E1) of the microsomal EtOH-oxidizing system (MEOS) in the ER, and catalase in peroxisomes catalyze the first oxidation step, which converts EtOH to AcAld, a toxic and reactive EtOH metabolite. ADH is quantitatively the most important first step enzyme, whereas CYP2E1 has a higher Km for EtOH than ADH. Thus, the relative contribution of CYP2E1 to overall EtOH metabolism increases with increasing blood EtOH concentration (Gonzalez et al., 1991; Leung and Nieto, 2013; Lu and Cederbaum, 2008) .
Aldehyde dehydrogenase (ALDH) further oxidizes AcAld to acetate. Of 19 ALDH isoforms, ALDH2 in the mitochondrial matrix is most important for AcAld oxidation, and thus, AcAld must enter mitochondria to be oxidized to acetate (Lieber, 2005) . Together, ADH and ALDH form 2 moles of NADH for each mole of EtOH oxidized to acetate. In the cytosol, ADH increases the NADH/NAD + ratio, and NAD + supply becomes rate limiting for the ADH reaction. Reducing equivalents of NADH formed by ADH enter mitochondria via the malate-aspartate or other shuttle for oxidation by the mitochondrial respiratory chain with regeneration of NAD + (Lieber, 2005) . Mitochondrial NADH formed after AcAld oxidation by ALDH2 must also be oxidized by the respiratory chain for EtOH oxidation to continue.
Swift Increase in Alcohol Metabolism
The liver is the major organ eliminating EtOH and its toxic metabolic AcAld to protect other organs, especially the central nervous system, after alcohol ingestion. Exposure to EtOH leads to an adaptive increase in EtOH metabolism in both rodent and human livers (Thurman et al., 1982; Videla and Israel, 1970; Yuki and Thurman, 1980b) . Occurring within 2 to 3 hours after EtOH treatment, this phenomenon is named swift increase in alcohol metabolism (SIAM) and is defined experimentally as a rapid increase in hepatic alcohol metabolism and mitochondrial respiration after a single bolus dose of alcohol (e.g., 5 g/kg), but even small doses (1 g/kg) can produce SIAM (Shimamoto et al., 2010; Thurman et al., 1982; Yuki and Thurman, 1980b) . SIAM also occurs in human subjects after alcohol consumption of 0.85 g/kg (Thurman et al., 1989) .
Although increased respiration should in theory lead to increased ATP generation, EtOH treatment actually decreases hepatic ATP by 50 to 60% (Bailey et al., 1999; ElAssal et al., 2004; Zhong et al., 2014) . Overall, the respiratory burst in SIAM is an adaptive response to oxidize toxic AcAld more rapidly by increasing NAD + supply for ADHand ALDH-dependent EtOH metabolism. This hepatic hypermetabolism persists during chronic EtOH exposure and was first described in a chronic EtOH feeding model (Han et al., 2012 (Han et al., , 2017 Israel et al., 1973 Israel et al., , 1975a Ribiere et al., 1994; Videla et al., 1973) . The mechanisms of SIAM are not well understood but most likely are multifactorial.
Occurrence of SIAM requires EtOH oxidation to AcAld (Bradford and Rusyn, 2005) . Neither MEOS nor hepatic ADH activity is altered when SIAM first develops after acute EtOH (Yuki and Thurman, 1980b) . However, ADH deficiency and inhibition, and to a lesser extent, cytochrome P450 inhibition, block SIAM (Glassman et al., 1985; Wendell and Thurman, 1979; Yuki and Thurman et al., 1980a) . Other studies suggest that catalase also plays a role in SIAM (Bradford et al., 1999) .
EtOH-Induced Voltage-Dependent Anion Channel Closure
The voltage-dependent anion channel (VDAC) is a highly conserved 30-kDa mitochondrial outer membrane protein with 3 isoforms in mice and humans-VDAC1, VDAC2, and VDAC3 (Neumann et al., 2010; Shoshan-Barmatz and Gincel, 2003) . VDAC forms a barrel comprised of a transmembrane alpha helix and 19 transmembrane beta strands enclosing a~2.5 nm aqueous channel, which in the open state allows passage of nonelectrolytes up to 5 kDa in size, although electrostatic profile is also an important determinant of channel permeance (Bayrhuber et al., 2008; Colombini, 2012) . Except for a relatively few membrane-permeant lipophilic compounds, metabolites that enter and leave mitochondria must cross the outer membrane through VDAC (Colombini, 2012; Shoshan-Barmatz and Gincel, 2003) . In the open state, anions are somewhat favored over cations. Membrane potential (DΨ) closes VDAC symmetrically with half maximal closure at AE50 mV. VDAC closure effectively blocks movement of most organic anions, including respiratory substrates, acyl-CoA, ATP, ADP, and Pi (Lemasters, 2017; Shoshan-Barmatz and Gincel, 2003; Vander Heiden et al., 2000) .
VDAC is generally assumed to be open during mitochondrial metabolism, but more recent data suggest that VDAC can close and inhibit metabolite exchange (Das et al., 2008; Holmuhamedov and Lemasters, 2009; Lemasters and Holmuhamedov, 2006; Vander Heiden et al., 2000) . Various degrees of VDAC closure modulate substrate supply for respiration, exchange of ADP and Pi for ATP during oxidative phosphorylation (OXPHOS), and other mitochondrial functions. In this way, VDAC acts as a dynamic limiter, or "governator," of global mitochondrial function (Lemasters, 2017; Lemasters and Holmuhamedov, 2006; Maldonado and Lemasters, 2012) .
As noted above, hepatic ATP paradoxically decreases after acute EtOH despite increased mitochondrial respiration and without activation of an identifiable ATPase. Moreover, steatosis occurs, indicative of inhibition of mitochondrial b-oxidation (Zhong et al., 2014) . However, rats fed triglycerides containing short-to medium-chain fatty acids have less steatosis after EtOH treatment than rats fed triglycerides containing long-chain fatty acids, indicating that mitochondria continue to metabolize shorter chain fatty acids after EtOH (Nanji, 2004) . To explain these phenomena, closure of VDAC was proposed to occur (Lemasters and Holmuhamedov, 2006) . In this way, VDAC becomes rate limiting for both release of mitochondrial ATP and uptake of fatty acylCoA to explain hepatic ATP depletion and steatosis. However, VDAC closure does not block mitochondrial oxidation of short-chain fatty acids and AcAld that pass directly through membrane lipid bilayers. Nonetheless, simple permeance of AcAld is insufficient to stimulate mitochondrial respiration over that supported by other respiratory substrates, because the respiration-driven protonmotive force across the inner membrane comprised predominantly of DΨ inhibits respiration, the well-known phenomenon of respiratory control. Thus, it was further hypothesized that mitochondrial uncoupling and depolarization must also occur to stimulate respiration during SIAM (see below) (Lemasters and Holmuhamedov, 2006) . Fig. 2 . AcAld suppression of rhodamine dextran entry into the mitochondrial intermembrane space of permeabilized rat hepatocytes. Digitonin-permeabilized rat hepatocytes were briefly incubated with 3-kDa rhodamine dextran (RhDex) to allow the red-fluorescing marker to enter the mitochondrial intermembrane space through VDAC. The VDAC inhibitor, 4,4-diisothiocyanatostilbene-2,2-disulfonic acid (DIDS), was added afterward to "lock-in" RhDex after subsequent RhDex washout. Green-fluorescing MitoTracker Green (MTG; Molecular Probes, Eugene, OR) marked the mitochondrial matrix. In comparison with untreated cells, pretreatment with AcAld (500 lM) decreased RhDex uptake. Nuclei are unspecifically stained by RhDex. Adapted from Holmuhamedov and colleagues (2012) .
Subsequent studies showed that outer membranes of hepatocellular mitochondria do indeed become less permeable to adenine nucleotides and low molecular weight dextrans after EtOH and AcAld exposure (Holmuhamedov and Lemasters, 2009) . Ureagenesis requires extensive exchange of different metabolites through VDAC. Both EtOH and AcAld suppress respiration stimulated by ureagenic substrates in cultured rat hepatocytes, and urea formation declines proportionately (Holmuhamedov et al., 2012) . For AcAld, the 50% inhibitory concentration (IC 50 ) is 125 lM. Inhibitors of AcAld-forming ADH, Cyp2E1, and catalase partially restore ureagenic respiration inhibited after EtOH treatment. By contrast, inhibition of ALDH exacerbates suppression of ureagenic respiration by EtOH. Additionally in plasma membrane-permeabilized rat hepatocytes, AcAld suppresses entry of 3-kDa rhodamine-conjugated dextran into the mitochondrial intermembrane space, indicative of VDAC closure ( Fig. 2) (Holmuhamedov et al., 2012) . These findings support the conclusion that AcAld underlies EtOH-induced inhibition of ureagenesis through closure of VDAC.
VDAC closure after EtOH becomes sufficient to be rate limiting for passage of anionic metabolites across the outer membrane. Such closure need not be complete. Moreover, in the "closed" state, VDAC becomes a cation selective pore of 1.8 nm in diameter that still conducts small anions like Cl À (Rostovtseva and Colombini, 1997; Tan and Colombini, 2007) . The mechanisms of EtOH-induced VDAC closure remain unknown. In cancer cells, free dimeric a,b-tubulin inhibits VDAC isoforms 1 and 2 but not the minor isoform VDAC3 (Maldonado et al., 2010 (Maldonado et al., , 2013 . a-Tubulin is a major target of adduct formation by AcAld, and adduction drastically impairs microtubule polymerization, which might increase free tubulin (Groebner and Tuma, 2015; Jennett et al., 1980; Tuma et al., 1991) . Kinase cascades may also be involved, since phosphorylation of VDAC by cAMPdependent protein kinase A (PKA) or glycogen synthase kinase-3b (GSK3b) enhances tubulin closure of VDAC reconstituted into bilayers (Sheldon et al., 2011) , whereas experiments in intact cells indicate that the PKA and GSK3b pathways increase and decrease, respectively, VDAC conductance (Das et al., 2008; Maldonado et al., 2010) . Phosphorylation by c-Jun N-terminal kinase-3 also decreases VDAC conductance (Gupta, 2017; Gupta and Ghosh, 2015) .
EtOH-Induced Mitochondrial Depolarization In Vivo
To examine whether mitochondrial uncoupling occurs to stimulate respiration during SIAM, mitochondrial polarization in vivo after EtOH treatment was assessed by intravital confocal/multiphoton microscopy, a technology that allows direct visualization of mitochondrial structure and function in living animals. If the process of OXPHOS remains intact during SIAM, mitochondrial DΨ should be preserved as respiration increases. Alternatively, if increased mitochondrial respiration is due to uncoupling, then DΨ should decrease sharply. What was observed is virtually complete mitochondrial depolarization (mtDepo), as assessed by the absence of mitochondrial uptake of DΨ-indicating cationic fluorophores like rhodamine 123 (Zhong et al., 2014) . This mtDepo occurs in an all-or-nothing fashion within individual hepatocytes. The percentage of hepatocytes with depolarized mitochondria increases in a dose-and timedependent fashion and peaks at 6 to 12 hours after single intragastric EtOH feeding (1 to 6 g/kg) ( Fig. 3) . At maximum EtOH (6 g/kg), mtDepo occurs in $ 90% of hepatocytes. At 1 g/kg EtOH, a dose causing a peak blood alcohol approximating the legal limit for operation of motor vehicles in the United States, mtDepo occurs in 10 to 15% of hepatocytes. mtDepo largely reverses after 24 hours as EtOH is metabolically eliminated and is virtually absent after 72 hours ( Fig. 3) (Zhong et al., 2014) .
High demand for O 2 during SIAM leads to zones of hypoxia, especially in pericentral (centrilobular) regions of liver lobules, which may contribute to liver injury (Arteel et al., 1996; Ji et al., 1982a Ji et al., ,b, 1983 . Nonetheless, EtOHinduced mtDepo is not secondary to anoxia, because NAD (P)H autofluorescence in depolarized mitochondria sharply decreases in comparison with adjacent hepatocytes with Fig. 3 . Acute EtOH causes reversible mitochondrial depolarization in vivo in a time-and dose-dependent manner. Mice were gavaged with 1 dose of EtOH (0 to 6 g/kg), and mitochondrial polarization was detected by intravital multiphoton microscopy of green-fluorescing rhodamine 123 at 0 to 24 hours after treatment. Representative images after treatment with 6 g/kg EtOH are shown in (A-C). Bar is 10 lm. (D) and (E) show, respectively, the time course of mtDepo after 6 g/kg EtOH and the dose dependency of mtDepo after 6 hours. Values are means AE SEM (n = 4 to 5 per group). *p < 0.05 versus no EtOH. Adapted from (Zhong and colleagues (2014) .
polarized mitochondria, whereas in anoxia, NAD(P)H increases maximally. mtDepo in combination with NAD(P) H oxidation and increased respiration (SIAM) are the hallmarks of uncoupling (Nieminen et al., 1997; Sies et al., 1974; Zhong et al., 2014) . In support of an uncoupling mechanism, hepatic ATP decreases~60% after acute EtOH (6 g/kg) (Zhong et al., 2014) . By increasing mitochondrial respiration, uncoupling is an adaptive response to promote NAD + regeneration in support ADH-and ALDH2-dependent alcohol metabolism.
Decreased entry into mitochondria of normal NAD + -linked substrates (pyruvate, acyl-CoA, etc.) cannot account for mtDepo and mitochondrial NADH oxidation, since hepatic oxygen consumption does not decrease but instead nearly doubles during SIAM. Rather, oxidation of membrane-permeant AcAld replaces oxidation of other anionic respiratory substrates whose entry into mitochondria is blocked by closure of VDAC after EtOH/AcAld exposure. Several mechanisms for mtDepo are possible, such as futile cycling of H + , Ca 2+ , K + , or other ion, but the specific mechanism remains unknown.
The mitochondrial permeability transition (MPT) is not responsible for EtOH-induced mtDepo in vivo, since the MPT blocker cyclosporin A (CsA) did not block EtOHinduced mtDepo, calcein did not redistribute from cytosol into the depolarized mitochondria, and mtDepo was reversible after acute EtOH (Zhong et al., 2014) . Simple activation of an ATPase to cause futile ATP hydrolysis seems unlikely, since mitochondrial DΨ falls by a relatively small amount during maximal ADP-stimulated state 3 respiration compared to the virtually complete mtDepo after EtOH (Nicholas and Ferguson, 2013) .
Uncoupling proteins (UCPs) depolarize mitochondria and stimulate respiration (Bouillaud et al., 2016; Diehl and Hoek, 1999) . In obesity, steatosis, and various pathological conditions, liver expresses UCP2 that promotes injury, but UCP2 protein and mRNA are virtually undetectable in normal lean livers (Chavin et al., 1999; Demori et al., 2008; Evans et al., 2008) . Thus, UCP2 up-regulation seems unlikely to account for mtDepo, since mtDepo begins at a very early time point (1 hour) after EtOH and because EtOHinduced mtDepo is not blocked in the livers of UCP2 deficient mice (Zhong et al., 2014; Zhong Z, Ramshesh VK, Lemasters JJ unpublished) .
Interestingly, mtDepo in vivo also occurs after chronic EtOH treatment, although the percentage of hepatocytes exhibiting mtDepo is less than after high-dose acute EtOH treatment (Rehman et al., 2015) . Thus, mitochondrial uncoupling also occurs after chronic alcohol consumption.
In support of such mitochondrial uncoupling in humans, energy expenditure increases whereas metabolic efficiency decreases in both acute and chronic drinkers (Jhangiani et al., 1986; Levine et al., 2000; Suter et al., 1994) .
In vivo, EtOH-induced mtDepo depends on AcAld formation (Zhong et al., 2014) . Deficiency of ADH, the major EtOH-metabolizing enzyme, decreases mtDepo after acute EtOH by~70%. Deficiency of CYP2E1 and pharmacological cytochrome P450 inhibition each decrease mtDepo after acute EtOH by~20%, indicating that ADH plays a greater role than CYP2E1 in mtDepo in vivo. Alda-1, an activator of ALDH2, also decreases mtDepo after acute EtOH, whereas inhibition of ALDH activity with disulfiram increases mtDepo (Zhong et al., 2014) . Alda-1 also decreases mtDepo after chronic EtOH treatment (Rehman et al., 2015) . Thus, increased AcAld levels during EtOH metabolism promote mtDepo after both acute and chronic EtOH exposure. Overall, increased intrahepatic AcAld after EtOH may act as a signal triggering multiple mitochondrial alterations to accelerate alcohol metabolism.
Because small neutral aldehydes like AcAld do not need VDAC or other carriers to cross the outer and inner membranes of mitochondria, VDAC closure and respiratory stimulation by mtDepo together promote rapid and selective oxidation of membrane-permeant AcAld while simultaneously inhibiting oxidation of competing substrates that require VDAC to enter mitochondria. VDAC closure also prevents futile hydrolysis of cytosolic ATP by uncoupled mitochondria such that tissue ATP levels can be partially maintained by glycolysis (Lemasters, 2017; Lemasters and Holmuhamedov, 2006; Zhong et al., 2014) . Nonetheless, some anion flux across the outer membrane must persist for electron transfer from cytosolic NADH to mitochondrial NAD + by the malate-aspartate or a-glycerol phosphate shuttle. This flux may be through incompletely closed VDAC or previously unrecognized exchange pathways in the outer membrane.
Similar mechanisms may also play a role in nonalcoholic steatohepatitis (NASH) in which oxidative stress is an important pathogenic mechanisms, since lipid peroxidation chain reactions generate small aldehydes like malondialdehyde that close VDAC even more potently than AcAld (Holmuhamedov et al., 2011 (Holmuhamedov et al., , 2012 . Although adaptive in promoting faster detoxification of aldehydes, VDAC closure and the associated mitochondrial uncoupling may become maladaptive hits in the multihit pathogenesis of ALD and possibly other forms of liver disease, such as NASH and vinyl chloride-related toxicant-associated steatohepatitis (Anders et al., 2016; Cave et al., 2010) , as further discussed below.
Mitophagy and EtOH-Induced Mitochondrial Remodeling
Mitochondrial autophagy, or mitophagy, is a process leading to lysosomal degradation of mitochondria in response to nutrient deprivation, mitochondrial damage, and the need for cytoplasmic remodeling as bioenergetic demands change (Kim et al., 2007; Lemasters, 2014) . Deficient mitophagy is associated with mitochondrial dysfunction and the pathogenesis of many diseases (Chistiakov et al., 2017; Jin and Youle, 2012; Redmann et al., 2014; , whereas overactive mitophagy can produce mitochondrial depletion and a bioenergetic deficit, as described for cadmium hepatotoxicity (Pi et al., 2013) . Different signaling pathways initiate mitophagy. In type 1 mitophagy, Vps34 (class III phosphoinositide 3-kinase [PI3K]), beclin-1, and other proteins initiate formation of cup-shaped phagophores that wrap around individual mitochondria and fuse to form mitophagosomes. Type 1 mitophagy often occurs coordinately with mitochondrial fission (Lemasters, 2014) . Type 1 mitophagy is typical of nutrient deprivation and cytoplasmic remodeling and is completely blocked by PI3K inhibitors like 3-methyladenine and wortmannin. In type 1 mitophagy, the outer compartment of mitophagosomes (space between the inner and outer autophagosomal membranes) acidifies, and then, mtDepo occurs (Fig. 4A) . Subsequently, mitophagosomes fuse with lysosomes (or late endosomes) to form autolysosomes in which hydrolytic digestion of mitochondria occurs within about 15 minutes (Eid et al., 2013; Lemasters, 2014) . Thus, type 1 mitophagy removes functional mitochondria to provide metabolic precursors during nutrient deprivation or that are in excess of metabolic needs (Lemasters, 2014; Rodriguez-Enriquez et al., 2009) .
In type 2 mitophagy, mtDepo initiates autophagic sequestration. After mtDepo, PINK1 accumulates on mitochondria to promote Parkin binding. Parkin is an E3 ligase, and ubiquitination of mitochondrial proteins recruits autophagy receptor proteins like p62/SQSTM-1, followed by association of LC3-containing membranes that appear to fuse to form an autophagosome enveloping the target mitochondrion (Lemasters, 2014) . By contrast to type 1 mitophagy of polarized mitochondria, PI3K inhibitors do not block type 2 mitophagy of depolarized mitochondria (Fig. 4A) . Moreover, cup-shaped phagophores and mitochondrial fission are typically absent in type 2 mitophagy (Lemasters, 2014; Pickles et al., 2018) . Other autophagy receptors, including BCL2/adenovirus E1B 19-kDa protein-interacting protein 3, Nix, optineurin, and double FYVE-containing protein 1, also associate with depolarized mitochondria to promote LC3 binding and autophagic sequestration (Kubli and Gustafsson, 2012; Schweers et al., 2007; Holzbaur, 2014, 2015) . In a third type of mitophagy, mitochondria-derived vesicles (MDVs) enriched in oxidized mitochondrial proteins bud off from mitochondria and transit to multivesicular bodies. Topologically, internalization of such MDVs by invagination of multivesicular bodies followed by vesicle scission into the lumen is a form of microautophagy. Such type 3 micromitophagy is also PINK1/ parkin-dependent (McLelland et al., 2014; Soubannier et al., 2012) .
Acute EtOH stimulates mitophagy, and this autophagy decreases acute EtOH-induced hepatotoxicity and steatosis in mice in a parkin-dependent fashion (Ding et al., 2010; Williams et al., 2015) . EtOH also causes oxidative mtDNA damage and depletion (Eid et al., 2016; Mansouri et al., 2001) . The effects of chronic EtOH on autophagy/mitophagy are somewhat controversial. Some studies show enhanced autophagic flux and increased autophagosome numbers, whereas others indicate that chronic EtOH disrupts autophagosomal processing and lysosomal function, leading to autophagosome accumulation (Eid et al., 2013; Kharbanda et al., 1995; Lin et al., 2013; Thomes et al., 2015) . In type 1 mitophagy, PI3K, beclin-1, and other proteins initiate formation of cup-shaped LC3-containing sequestration membranes (phagophores) that fuse around individual mitochondria to form mitophagosomes, often with coordinated mitochondrial fission. PI3K inhibitors like 3-methyladenine (3-MA) and wortmannin block type 1 mitophagy. In type 1 mitophagy, mtDepo does not occur until after sequestration and acidification of mitophagosome outer compartments (space between the inner and outer autophagosomal membranes). Subsequently, mitophagosomes fuse with lysosomes to form autolysosomes in which mitochondrial digestion is complete within about 15 minutes. Type 1 mitophagy is typical of nutrient deprivation and removal of unneeded mitochondria. In type 2 mitophagy, mtDepo initiates autophagic sequestration through association of PINK1 and Parkin and subsequent ubiquitination of mitochondrial proteins to recruit autophagy receptor proteins like p62/SQSTM-1. LC3-containing membrane vesicles then associate with the depolarized mitochondria and fuse to form autophagosomes. By contrast to type 1 mitophagy, PI3K inhibitors do not block type 2 mitophagy, and cup-shaped phagophores and mitochondrial fission are absent. (B) We propose the hypothesis that EtOH-induced mtDepo stimulates type 2 mitophagy. After high-dose binge drinking, extensive mtDepo likely overwhelms cellular capacity to form mitophagosomes, whereas after chronic EtOH, capability for subsequent autophagic processing (delivery of mitophagosomes to lysosomes) becomes compromised. Such dysregulation of autophagy leads to extracellular release of damaged mitochondria, mitophagosomes, and/or autolysosomes by fusion with the plasma membrane or exosome formation. mtDAMPs released in this way then promote liver injury, inflammation, and fibrosis. mtDAMPs are also likely released internally to activate intracellular inflammasomes (not illustrated).
Nuclear translocation of transcription factor EB (TFEB), the master regulator of lysosomal biogenesis, increases after acute EtOH but decreases after chronic EtOH in mice and in patients with AH, implying suppressed lysosomal biogenesis and autophagy after chronic EtOH (Chao et al., 2018; Thomes et al., 2015) . TFEB overexpression decreases chronic EtOH plus binge drinking-induced liver injury (Chao et al., 2018) . mtDepo triggers type 2 mitophagy (Hariharan et al., 2011; Kim et al., 2008; Lemasters, 2014; Narendra et al., 2008) . Thus, mtDepo after EtOH likely initiates hepatocellular mitophagy. In confirmation, experiments in LC3-GFP transgenic mice show that LC3-GFP mitophagic puncta appear predominantly in hepatocytes with depolarized mitochondria after acute EtOH, implicating strongly that EtOHinduced mtDepo induces mitophagy (Fig. 5) . PINK1 also increases after chronic EtOH, indicating PINK1 stabilization on depolarized mitochondria, whereas blunting of mtDepo by Alda-1 decreases PINK1 accumulation (Rehman et al., 2015) . Other studies also show that PINK1 and parkin mediate mitochondrial autophagy after acute and chronic-binge EtOH (Eid et al., 2016; Williams et al., 2015) . MPT inhibitors like CsA and NIM811 can inhibit hepatocellular autophagy, and deficiency of cyclophilin D, a regulator of MPT pores, impairs autophagy and decreases the sensitivity to the MPT in mitochondria from mice after chronic alcohol treatment, implicating a possible role of the MPT in triggering autophagy (Elmore et al., 2001; King et al., 2014; Rodriguez-Enriquez et al., 2009) . VDAC isoforms may serve as the docking sites to recruit parkin onto damaged mitochondria and are the target of parkin-dependent ubiquitination, thus enhancing mitophagy (Geisler et al., 2010; Sun et al., 2012) . By decreasing mitochondrial release of ATP, VDAC closure after EtOH might also trigger some degree of nutrient deprivation-dependent type 1 mitophagy.
To maintain mitochondrial homeostasis after mitophagy, loss of mitochondria must be matched by mitochondrial biogenesis. In support of enhanced mitochondrial biogenesis, intragastric alcohol feeding increases PGC-1a, the master regulator of mitochondrial biogenesis, and mitochondrial transcription factor A (TFAM), an activator of mitochondrial DNA transcription and participant in mtDNA replication (Han et al., 2012 (Han et al., , 2017 . Nonetheless, alterations of PGC-1a, sirtuins, the deacetylases that regulate PGC-1a activity, and OXPHOS proteins after chronic EtOH treatment are inconsistent between studies (Han et al., 2012 (Han et al., , 2017 Lieber et al., 2008a,b) . Taken together, alterations of mitochondrial structure, function, mitophagy, and biogenesis indicate that mitochondrial remodeling occurs after chronic alcohol, which may represent repair and regeneration responses or contribute to ALD pathogenesis.
LINKAGE OF HEPATIC ADAPTATIONS FOR ETOH METABOLISM TO EXTRAHEPATIC EVENTS
The gut-liver axis plays an important role in both adaptive EtOH metabolism and the pathogenesis of ALD (Scarpellini et al., 2016; Szabo and Petrasek, 2017; Thurman et al., 1998; Xu et al., 2017) . Alcohol consumption changes the gut microbiome, causing bacterial overgrowth and increasing formation of toxic/proinflammatory products (Engen et al., 2015; Mutlu et al., 2012; Yan et al., 2011) . Alcohol also increases intestinal permeability, possibly by altering expression of tight junction-associated proteins (Enomoto et al., 2001; Rivera et al., 1998; Thurman et al., 1998; Wang et al., 2014) . As a result, bacterial components (e.g., endotoxin [lipopolysaccharide (LPS)] and bacterial CpG-containing DNA) increase in portal blood after acute and chronic EtOH exposure in humans and experimental animals (Bala et al., Fig. 5 . Mitophagy is associated with mtDepo after acute EtOH treatment. Male LC3-GFP transgenic mice were gavaged with saline (A) or EtOH B; (4 g/kg), and intravital multiphoton microscopy was performed after 4 hours of red-fluorescing TMRM, which accumulates into polarized mitochondria, and green-fluorescing LC3-GFP, a marker of forming and newly formed autophagosomes. After EtOH, note an increase in green LC3-GFP puncta in hepatocytes with mtDepo. Bar is 10 lm 2014; Bode et al., 1987; Enomoto et al., 2000a; Fukui et al., 1991; Rivera et al., 1998) .
The gut-liver axis also modulates SIAM (Bradford et al., 1993) . Gut sterilization and an endotoxin antagonist block SIAM, whereas portal endotoxin infusion mimics the stimulation by EtOH of hepatic oxygen uptake. This latter effect is blocked by the Kupffer cell toxicant GdCl 3 Rivera et al., 1998) . Endotoxin activates Kupffer cells via Toll-like receptor 4 (TLR4), which stimulates release of reactive mediators, including proinflammatory and profibrotic cytokines/chemokines (e.g., tumor necrosis factor-a [TNF-a], interleukins, monocyte chemoattractant protein 1), and reactive oxygen and nitrogen species (ROS and RNS) (Enomoto et al., 2000b; Nolan, 2010; Thurman et al., 1995; Wheeler et al., 2001a; Xu et al., 2017) . Endotoxin in combination with EtOH feeding causes overt liver injury, but endotoxin alone does not cause or only causes mild steatohepatitis (Bhagwandeen et al., 1987; Kong et al., 2017) . Moreover, diseases that release endotoxin into the portal blood, such as Crohn's disease, ulcerative colitis, and celiac disease, do not manifest the hepatic histopathology of ALD (Rojas-Feria et al., 2013; Rubio-Tapia and Murray, 2008) . Thus, endotoxin is not a sole or sufficient etiological agent in ALD and somehow must act in a synergistic fashion with other EtOH-induced changes.
Kupffer cells also release eicosanoids like prostaglandin E 2 (PGE 2 ). Kupffer cells isolated from rats receiving EtOH in vivo produce PGE 2 , and conditioned medium from these cells stimulates hepatocyte oxygen uptake by activating cAMP-dependent pathways (Qu et al., 1996) . PGE 2 increases in blood after acute EtOH (Enomoto et al., 2000c; Rivera et al., 1998) . Thus, endotoxin activation of Kupffer cells causes PGE 2 production, an effect that is, at least in part, responsible for SIAM. Although SIAM seems linked to mtDepo, how the gut-liver axis and Kupffer cell activation may promote mtDepo remains to be determined.
Hormones are also linked to SIAM. Alcohol increases adrenergic hormone release, and adrenalectomy and adrenergic blockers suppress SIAM (Forman et al., 1988; Yuki et al., 1980) . Thyroidectomy and hypophysectomy also blunt the hypermetabolic state after EtOH (Bernstein et al., 1975; Israel et al., 1975a) . Females are more vulnerable to ALD than males, and estrogen enhances sensitivity of Kupffer cells to endotoxin and worsens EtOH-induced liver injury, possibly by increasing expression of CD14 (a coreceptor for LPS) and LPS-binding protein Ikejima et al., 1998; Kono et al., 2002) . By contrast, fasting blunts SIAM, implicating potential roles for increased glucagon or decreased insulin in suppressing SIAM (Thurman and Scholz, 1977) . Adipose-derived leptin, a hunger-inhibiting hormone, also increases after EtOH consumption and up-regulates Kupffer cell CD14 expression, which could increase sensitivity of Kupffer cells to LPS and therefore possibly SIAM (Imajo et al., 2012; Roth et al., 2003) .
ADAPTIVE ALCOHOL METABOLISM AND OXIDATIVE STRESS
EtOH consumption also promotes hepatic ROS and RNS formation (Hoek and Pastorino, 2004; Wheeler et al., 2001b; Yin et al., 2001) . EtOH increases CYP2E1, largely by a posttranscriptional mechanism involving stabilization against proteolysis (Gonzalez et al., 1991; Lu and Cederbaum, 2008) . CYP2E1 generates superoxide (O 2 ÁÀ ), which then forms highly reactive peroxynitrite (ONOO À ) by reaction with NO, and hydroxyl radical ( Á OH) by the Fenton reaction (Jaeschke et al., 2002; Lemasters, 2004) . In the presence of EtOH, 1-hydroxyethyl radical is also formed . Therefore, ROS, RNS, and other radical species all increase after EtOH. These radicals attack and damage proteins, lipids, and DNA, induce onset of the MPT, cause cell death, and trigger inflammatory processes (e.g., by inflammasome activation) (Hughes and O'Neill, 2018; Jaeschke et al., 2002) . In particular, lipid peroxidation downstream to Á OH formation generates toxic aldehydes like malondialdehyde and 4-hydroxynonenal that promote VDAC closure and possibly EtOH-induced mtDepo. Steatosis resulting from VDAC closure and consequent inhibition of beta-oxidation may then increase the vulnerability to lipid peroxidation, creating a vicious cycle.
During mitochondrial metabolism, electrons can escape from 11 identified ubiquinone and flavoquinone-interacting respiratory complexes and dehydrogenases to form O 2 ÁÀ and H 2 O 2 (Brand, 2016; Bunik and Brand, 2018; Kovacic et al., 2005; Young et al., 2002) . SIAM accelerates NADH oxidation by the respiratory chain, promoting mitochondrial production of ROS, although decreased DΨ in the absence of other mitochondrial perturbations suppresses ROS formation Garcia-Ruiz et al., 2013; Han et al., 2017; Korshunov et al., 1997; Starkov and Fiskum, 2003; Zhong et al., 2014) . EtOH also increases CYP2E1 expression in mitochondria (Anandatheerthavarada et al., 1997; Bansal et al., 2010; Robin et al., 2005) .
Cu/Zn superoxide dismutase (SOD1) in the cytosol and Mn SOD2 in the mitochondrial matrix scavenge O 2
ÁÀ
. Various reports show increased, decreased, and unchanged Mn-SOD after EtOH treatment (Koch et al., 1994; Nanji et al., 1995) . In the intermembrane space, cytochrome c can scavenge O 2 ÁÀ forming ferrocytochrome c. Glutathione-linked antioxidant defenses also reside in mitochondria, including GSH peroxidase-1, peroxiredoxin-III, thioredoxin-2, and glutathione reductase. Alcohol consumption selectively depletes mitochondrial GSH, thus increasing mitochondrial oxidative stress (Fernandez-Checa and Kaplowitz, 2005) . AcAld aggravates oxidative stress by binding to GSH and promoting GSH leakage (Lieber, 2004) . Since GSH, like other metabolites, must pass through VDAC to be taken up into mitochondria, alcohol-induced VDAC closure may also contribute to decreased mitochondrial GSH. Increased consumption of mitochondrial GSH during antioxidant defense causes further depletion.
Oxidative stress also stimulates ER stress. Moreover, EtOH causes ER stress through disturbance of 1 carbon metabolism, increased homocysteine, and activation of acid sphingomyelinase Ji and Kaplowitz, 2003) . ATP depletion during SIAM may also promote ER stress. ER stress increases expression of StARD1, a mitochondrial cholesterol transporting polypeptide, leading to mitochondrial cholesterol accumulation, which reportedly inhibits mitochondrial GSH transport to exacerbate mitochondrial GSH depletion and promote ROS production, thus forming a vicious cycle (Anuka et al., 2013; Mari et al., 2008) .
RELATION OF ETOH-INDUCED MITOCHONDRIAL ALTERATIONS TO PATHOGENESIS OF ALD
Adaptive EtOH Metabolism and Steatosis
Steatosis is a virtually universal feature of ALD except in advanced alcoholic cirrhosis (Magdaleno et al., 2017) . After chronic EtOH, decreased adiponectin, suppressed expression/activation of hepatic PPAR-a and AMPK, disrupted SIRT-1/SREBP-1/lipin-1 signaling, and ER stress inhibit fatty acid oxidation and increase fatty acid esterification (Ajmo et al., 2008; Correnti et al., 2014; Garcia-Villafranca et al., 2008; Ji and Kaplowitz, 2006; Song et al., 2008; Yin et al., 2012) . Alcohol also activates adipose hormone-sensitive lipase activity, which increases lipolysis in adipose tissue and mobilizes free fatty acids to other organs, including the liver. In this way, the liver faces an increased fatty acid burden (Dou et al., 2014; Wood et al., 1993; Zhong et al., 2012) .
Steatosis develops very quickly after acute EtOH treatment and in parallel with SIAM. Thus, adaptive mitochondria alterations for alcohol metabolism likely play an early role in development of steatosis. Intravital microscopy shows that steatosis occurs principally in hepatocytes with depolarized mitochondria after acute EtOH treatment, strongly implying that steatosis is a response to mtDepo (Zhong et al., 2014) (Fig. 6) . VDAC closure linked to adaptive alcohol metabolism also inhibits entry of fatty acyl-CoA into the matrix space to prevent beta-oxidation, thus promoting steatosis. Similarly, hepatotoxicants that suppress mitochondrial fatty acid entry, inhibit beta-oxidation enzymes, or impair OXPHOS all induce marked hepatic steatosis quite acutely Lemasters, 2013; Pessayre et al., 2012) .
Additionally, pericentral hypoxia associated with SIAM up-regulates hypoxia-inducible factor-1a (HIF-1a) (Arteel et al., 1996; Ji et al., 1982a; Zhong et al., 2014) . HIF-1a protein induces expression of adipocyte differentiation-related protein (ADRP), which increases triglyceride accumulation and prevents secretion of triglycerides/VLDL in cultured hepatocytes (Magnusson et al., 2006; Nath et al., 2011) . Hepatocyte-specific HIF-1a knockout blocks chronic alcohol-induced ADRP expression in the liver and decreases steatosis (Nath et al., 2011) . Therefore, adaptive mitochondria alterations for alcohol metabolism not only inhibit fatty acid degradation but also prevent triglyceride exportation.
EtOH-Induced Mitochondrial Alterations and Cell Death
After high acute EtOH, cell death in liver is actually quite small at about 2%, which makes this phenomenon difficult to study (Zhong et al., 2014) . In chronic ALD, loss of hepatocellular mass is progressive and eventually leads to liver failure (Magdaleno et al., 2017; Wang et al., 2016a) . Apoptosis and necrosis both occur (Gao and Bataller, 2011; Ishak et al., 1991; Tsukamoto et al., 1985) . Acute and chronic alcohol treatment causes oxidative modifications of mtDNA, which may trigger apoptosis (Hoek et al., 2002) . AcAld also causes mtDNA damage, and mtDNA deletions occur in >60% of patients with alcoholic steatosis . Progressive loss of hepatocytes signifies a failure of hepatocellular regeneration, which is otherwise extraordinary in liver, an effect that may be due to AcAld-mediated G2/M cell cycle arrest (Diehl, 2005; Scheer et al., 2016) . Compromised bioenergetics in hepatocytes with mtDepo may also contribute to failure of regeneration. Fig. 6 . EtOH causes steatosis in hepatocytes with depolarized mitochondria. Mice were gavaged with saline (A) or EtOH (B; 6 g/kg), and intravital microscopy of TMRM (red) and the lipid droplet-labeling fluorophore, BODIPY 493/503 (green), was performed after 2 hours. Note presence of lipid droplets predominantly in hepatocytes with mtDepo. Bar is 10 lm. Adapted from Zhong and colleagues (2014) .
Oxidative stress also triggers onset of the MPT (Hoek et al., 2002; Malhi et al., 2006; Nieminen et al., 1995) . In cultured hepatocytes, EtOH causes formation of ROS, the MPT, and apoptosis (Adachi and Ishii, 2002) . However, the MPT is not responsible for EtOH-induced mtDepo in vivo, as discussed above ("EtOH-Induced Mitochondrial Depolarization In Vivo" section) (Zhong et al., 2014) . Nonetheless, mitochondria isolated from rats chronically treated with EtOH show increased susceptibility to MPT onset, which may increase vulnerability to other coexisting risk factors and lead to exacerbation/progression of ALD (King et al., 2014) . High cholesterol intake, which further increases ER stress and mitochondrial ROS production, causes more necrosis and apoptosis after chronic alcohol feeding in mice (Krishnasamy et al., 2016) .
VDAC closes relatively early in the evolution of apoptosis with the consequence that mitochondria no longer release ATP to the cytosol or take up ADP, Pi, and respiratory substrates (Shoshan-Barmatz and Golan, 2012; Vander Heiden et al., 2000) . EtOH-induced oxidative stress promotes Bax translocation to mitochondria, forming a complex with VDAC (Adachi et al., 2004) . VDAC manifests higher permeability to Ca 2+ in the closed state, favoring Ca 2+ flux into mitochondria, which is a signal for cell death (Tan and Colombini, 2007) . Nonetheless, the specific relationship of mitochondrial metabolic adaptations for EtOH metabolism (VDAC closure and mtDepo) to hepatocellular killing remains to be determined. Inflammasome Activation. Inflammasomes are large inflammatory signaling platforms localized to both mitochondria and ER, which are composed of NOD-like receptor proteins (NLRP), caspase-1, and apoptosis-associated specklike CARD-domain-containing (ASC) protein (Gurung et al., 2015; Schroder et al., 2010; Zhou et al., 2011) . In response to "danger signals," NLRP activates caspase-1, also called interleukin-1 (IL-1)-converting enzyme, which proteolytically cleaves precursors of proinflammatory cytokines like IL-1b, IL-18, and the pyroptosis inducer gasdermin D to yield active mature peptides (Gurung et al., 2015; Yu and Finlay, 2008) . AH patients have high IL-1 in blood and increased hepatic NLRP3, caspase-1, and activated gasdermin D (Khanova et al., 2018; McClain et al., 1986; Peng et al., 2014; Tilg et al., 2016) . NLRP3 and caspase-1 deficiency and IL-1b receptor blockade decrease alcohol-induced liver inflammation and damage (Petrasek et al., 2012 Tilg et al., 2016) . These findings support a role of inflammasome activation in AH.
Relation of EtOH
Danger signals from mitochondria, such as ROS, mtDNA, and cardiolipin externalization to the outer membrane, promote NLRP3 inflammasome formation and sterile inflammation (Gurung et al., 2015; Iyer et al., 2013; Shimada et al., 2012; Zhou et al., 2011) . EtOH exposure induces acetylation of a-tubulin, which then could promote association of ASC on mitochondria with NLRP3 on ER, leading to NLRP3 activation (Misawa et al., 2013; Shepard and Tuma, 2009) . In human subjects, EtOH consumption increases serum uric acid and ATP, 2 strong inflammasome stimulators (Lieber et al., 1962; Petrasek et al., 2015; Stiburkova et al., 2014) . ATP activates inflammasomes by binding to purinergic receptor P2X7 (P2X7R). P2X7R deficiency decreases EtOH-induced inflammasome activation and steatohepatitis . Uric acid depletion by uricase overexpression also decreases EtOH-induced inflammasome activation . Our recent findings show that chronic EtOH treatment increases NLRP3 inflammasome activation in mice and that blockade of mtDepo by Alda-1 attenuates NLRP3 activation and liver inflammation (Rehman et al., 2015) . Thus, adaptive EtOH metabolism may be upstream of inflammasome activation after EtOH.
NLRP3 activation not only mediates inflammation but also stimulates fibrosis. Mice with constitutively activated NLRP3 exhibit increased HSC activation with collagen deposition, whereas mice lacking NLRP3 and ASC protein show decreased CCl 4 -and TAA-induced liver fibrosis (Watanabe et al., 2009; Wree et al., 2014) . IL-1b directly induces fibrogenic responses in HSCs, and deficiency and inhibition of IL-1 receptor decrease steatohepatitis and fibrosis in a NASH model (Miura et al., 2010; Wree et al., 2014) .
Mitochondrial Damage-Associated Molecular Pattern Molecules. Mitochondrial stress and damage lead to the release into the cytosol and/or extracellular space of mitochondrial damage-associated molecular pattern (mtDAMP) molecules, including mtDNA, ATP, formyl peptides, cardiolipin, cytochrome c, succinate, and TFAM, which activate immune responses (Arnoult et al., 2011; Nakahira et al., 2015; Raoof et al., 2010) . We propose that mtDepo associated with adaptive EtOH metabolism triggers mitophagy. As autophagic processing of depolarized mitochondria and mitophagosomes becomes compromised during chronic EtOH exposure, mtDAMPs leak to the cytosol and are released extracellularly by exosome formation or fusion of depolarized mitochondria, mitophagosomes, or autolysosomes with the plasma membrane (Fig. 4) . In immune cells, insufficiency or discoordination of autophagy leads to release of autophagosomal/autolysosomal contents as inflammatory mediators (Bhattacharya et al., 2014; Fesus et al., 2011; Lapaquette et al., 2015) . If after EtOH a markedly increased autophagic burden overwhelms the lysosomal processing capacity, or if normal processing of autophagosomes is suppressed, then release of mtDAMPs is likely to occur. Indeed, chronic EtOH disrupts autophagosomal processing and lysosomal function (Chao et al., 2018; Kharbanda et al., 1995; Thomes et al., 2015) . Moreover, mtDAMPs increase after EtOH Rehman et al., 2015; Rolla et al., 2001) . For example, after chronic EtOH treatment in mice, we found that mtDNA increases in serum, an event associated with mtDepo (Rehman et al., 2015) . mtDNA stimulates TLR9, which in turn activates p38-MAPK in neutrophils (West et al., 2011; Zhang et al., 2010a,b) . mtDAMPs up-regulate MyD88 and NF-jB, increase cytokines TNF-a, IL-1, IL-6, and IL-10, and induce cell death (Hu et al., 2015; Miura et al., 2010) . IgG recognizing oxidized cardiolipin also increases in ALD patients (Rolla et al., 2001) . Overall, mitochondrial stress/dysfunction associated with EtOH exposure appears to exacerbate inflammation through mtDAMP release and inflammasome activation. mtDAMPs may also stimulate fibrosis. In a zebrafish alcoholic fatty liver model, succinate is released, and succinate is known to activate HSC through G-protein-coupled receptor-91 (Jang et al., 2012; Li et al., 2015) . Another mtDAMP, mtDNA, binds to TLR9. TLR9 is expressed in HSC, and activation of TLR9 directly causes HSC activation and fibrosis Gabele et al., 2008) . Nonetheless, information regarding the profile and time course of mtDAMP release in ALD, the relation of mtDAMPs to ALD severity, and which mtDAMPs are most critical for ALD pathogenesis is currently very limited.
In addition to mtDAMP release and inflammasome activation, some other events related to mitochondrial alterations due to adaptive alcohol metabolism may also contribute to fibrosis. Oxidative stress and mitochondrial dysfunction stimulate expression of osteopontin (OPN), a multifunctional protein that can induce activation, migration, and collagen production by HSCs (Riew et al., 2017; Wen et al., 2016; Zhang et al., 2017) . Expression of OPN and its receptors increases in animals and cells treated with EtOH and in patients with ALD (Apte et al., 2005; MoralesIbanez et al., 2013; Seth et al., 2006 Seth et al., , 2014 . Oxidative stress also promotes formation of profibrogenic TGFb (Barnard et al., 1990; Yue and Mulder, 2001 ). HIF-1a, which is upregulated after EtOH consumption due to hypoxia, induces expression of profibrogenic genes (Higgins et al., 2008) . Together, persistence of mitochondrial responses to EtOH links adaptive EtOH metabolism to maladaptive proinflammatory and profibrotic changes initiating onset and progression of ALD.
CONCLUSIONS AND FUTURE DIRECTIONS
After EtOH consumption, a respiratory burst occurs due to mtDepo in the liver. Such mitochondrial uncoupling after EtOH treatment occurs coordinately with VDAC closure (Fig. 7) . These alterations promote more rapid and selective oxidation of toxic AcAld by inhibiting oxidation of competing respiratory substrates, including fatty acyl-CoA, and by more rapidly regenerating NAD + needed for EtOH oxidation to acetate. VDAC closure also limits futile mitochondrial ATP hydrolysis that would otherwise occur after uncoupling. Depolarization in turn activates mitophagy that may have the function of removing mitochondria damaged by EtOHdependent oxidative stress, an apparent protective mechanism. Mitochondrial remodeling and biogenesis subsequently occur to restore mitochondrial homeostasis.
After chronic alcohol, an excessive mitophagic burden leads to dysfunctional autophagic processing and release of mtDAMPs intracellularly and extracellularly to activate inflammasomes and other receptors that mediate inflammatory/profibrotic responses. We propose that such mtDAMP release is a primary proinflammatory/profibrotic event in ALD (Fig. 7) . mtDAMPs then synergize with a variety of other proinflammatory/profibrotic events, especially in relation to endotoxin uptake from the gut. Although adaptive alcohol metabolism is a response to remove EtOH and its toxic metabolites more rapidly, the same adaptation occurring chronically appears to promote mitochondrial and autophagic dysfunction. Such dysfunction may then act as a tipping point from adaptation to maladaptation, leading to other pathogenic consequences in ALD including (i) steatosis due to inhibited beta-oxidation, (ii) mitochondrial glutathione Fig. 7 . Working hypothesis for how EtOH metabolism-associated mitochondrial alterations contribute to development of ALD. After EtOH consumption, a respiratory burst (↑J 02 ) develops due to mitochondrial uncoupling and mtDepo (↓DΨ) in the liver, and VDAC closure occurs. AcAld and gut-derived endotoxin acting through Kupffer cells and possibly PGE 2 promote mtDepo, whereas VDAC closure is promoted by AcAld. VDAC blocks uptake of fatty acyl-CoA for b-oxidation, which leads to acute steatosis. These adaptive mitochondrial alterations promote more rapid and selective oxidation of toxic AcAld by inhibiting oxidation of competing respiratory substrates and by more rapidly regenerating NAD + needed for EtOH oxidation to acetate. Depolarization in turn activates mitophagy. Although adaptive alcohol metabolism detoxifies EtOH more rapidly, the same metabolism occurring chronically becomes a tipping point from adaptation to maladaptation, leading to the pathogenic consequences of ALD. With chronic EtOH, excessive mitophagic burden leads to dysfunctional autophagic processing and release of mtDAMPs intracellularly and extracellularly. VDAC closure also blocks mitochondrial glutathione uptake, leading to oxidative and ER stress. Decreased ATP also promotes ER stress and possibly impaired hepatic regeneration. Together these maladaptive changes culminate inflammation, steatohepatitis, cell death, and fibrosis.
depletion, (iii) oxidative stress, (iv) ER stress, and (v) cell death. Perhaps most importantly, mtDAMP release enhances other inflammatory and profibrogenic responses to EtOH, thus exacerbating hepatitis and leading to fibrosis (Fig. 7) . In this way, adaptive mitochondrial alterations for alcohol metabolism constitute an initial "hit" in the multihit pathogenesis of ALD that converges and synergizes with other EtOHdependent events in the gut, endocrine system, and adipose tissue to promote development and progression of ALD.
Future studies are needed to elucidate further the mechanisms and pathogenic effects of adaptive alcohol metabolism/mitochondrial alterations in ALD, including the following: (i) Determining how EtOH causes mtDepo. For example, do Kupffer cells release mediators like PGE 2 to cause heterogeneous mtDepo in nearby hepatocytes? (ii) Identifying the uncoupling circuit in mitochondria that causes EtOH-induced mtDepo. Multiple depolarizing mitochondrial ion channels and transporters, such as the mitochondrial ATP-sensitive potassium channel, adenine nucleotide transporter, Ca 2+ transporters, and the F O portion of ATP synthase might underlie mtDepo. (iii) Elucidating the mechanism of EtOH-induced VDAC closure. How do phosphorylation, acetylation, and AcAld adduct formation modify VDAC conductances after EtOH? (iv) Better characterizing the relation of mtDepo, mitophagy, and mtDAMP release, particularly the mechanisms by which chronic EtOH impairs lysosomal processing and leads to mtDAMP release. (v) Identifying which specific mtDAMPs are most important in promoting ALD and how these mtDAMPs act on effector cells of inflammation and fibrosis. (vi) Clarifying the role of mitochondrial biogenesis and remodeling in repair and regeneration processes in ALD. Such new information will potentially lead to useful new biomarkers to monitoring ALD development/severity (e.g., mtDAMPs) and novel therapeutic strategies (e.g., mtDepo blockade, enhancing mitophagosome processing, and antagonists of mtDAMPs).
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